Co-expression of CDX2 and MUC2 in gastric carcinomas: Correlations with clinico-pathological parameters and prognosis

doi:10.3748/wjg.v11.i21.3182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3397)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

397

HTML

2679

Figures (1-1)

187

Tables (1-5)

134

Sum=3397

Jun 7, 2005 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 7, 2005; 11(21): 3182-3188
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3182

Full Size Figure Download Figure

Figure 1 Supranuclear CDX2 immunostaining in non-neoplastic gastric mucosa (A), signet-ring cell carcinoma (B) and tubular adenocarcinoma (C) of the stomach. MUC2 expression in non-neoplastic gastric tissue (D), signet-ring cell (E) and tubular adenocarcinoma (F).

Citation: Roessler K, Mönig SP, Schneider PM, Hanisch FG, Landsberg S, Thiele J, Hölscher AH, Dienes HP, Baldus SE. Co-expression of CDX2 and MUC2 in gastric carcinomas: Correlations with clinico-pathological parameters and prognosis. World J Gastroenterol 2005; 11(21): 3182-3188
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3182.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3182